Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.87 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.58 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.58 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.46 |
| ▸ | CD69 | Q07108 | 1/20 | 0.44 |
| ▸ | TLR4 | O00206 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17091443 | 1.00 | MAPK1 (0.87) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL17208459 | 1.00 | MAPK1 (0.87) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL17091444 | 1.00 | MAPK1 (0.87) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| Methacrylic Acid SCHEMBL21879320 | 0.94 | MAPK1 (0.77) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL25480942 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL7722124 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL15334244 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL7715068 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL19246175 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 | |
| SCHEMBL7718406 | 0.93 | MAPK1 (1.00) | MAPK1LGALS8LGALS3LGALS4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015140160-A1 | MICELLAR NANOPARTICLES CONTAINING ANTITUMORAL GLYCOSIDES | FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (ES) | 2015-09-24 | — | — | WO | claimed |
| EP-2921179-A1 | Micellar nanoparticles containing antitumoral glycosides | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) | 2015-09-23 | — | — | EP | claimed |
| WO-2018057649-A1 | TAGGED POLY(ESTER AMIDE URETHANE)S, NANOPARTICLES FORMED FROM SAME, AND USES THEREOF | CORNELL UNIVERSITY (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20150307539-A1 | USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH, MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2015-10-29 | — | — | US | disclosed |
| US-20150307539-A1 | USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH, MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2015-10-29 | — | — | US | disclosed |
| WO-2015140160-A1 | MICELLAR NANOPARTICLES CONTAINING ANTITUMORAL GLYCOSIDES | FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (ES) | 2015-09-24 | — | — | WO | disclosed |
| EP-2921179-A1 | Micellar nanoparticles containing antitumoral glycosides | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) | 2015-09-23 | — | — | EP | disclosed |
| EP-2871183-A1 | USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH AND MYELINATION AND INHIBITORS OF THE PROLIFERATION OF ASTROGLIA AND MICROGLIA | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2015-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307539-A1 | USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH, MYELINATION AND INHIBITING THE PROLIFERATION OF ASTROGLIA AND MICROGLIA | BDNF, MAG, NTRK2 | MAPK1 91/4885LGALS8 2902/4885LGALS3 372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.